Learn more about Antarctic sea squirts and how they could one day help with advanced melanoma treatments.

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest moments—revealing how lung cells with cancer-causing mutations recruit ...

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole chromosomes, changes that help tumors grow, adapt and resist treatment. In ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.

Moffitt Cancer Center researchers have developed ALFA-K, a new tool that they say can predict how cancer cells survive and compete. This new algorithm offers a potential roadmap for more effective, ...

Researchers at the University of Cologne's Center for Molecular Medicine Cologne (CMMC) have discovered a previously unknown ...

Many modern cancer treatments, including immunotherapy, depend on activating killer T cells to recognise and destroy tumours.

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...

A Moffitt Cancer Center researcher has introduced a new model that addresses one of biology's most fundamental questions: How does genetic information keep living systems organized and therefore alive ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor’s earliest moments — revealing how lung cells with cancer-causing mutations recruit ...